CD8A and HIV infectious disease: As discussed at a recent NIH-sponsored meeting on ‘T and B cell synergy for HIV vaccines’, an effective vaccine strategy to prevent and/or cure HIV infection will likely require induction of both an effective antibody response (i.e., bNAbs elicited and maintained at a high titer) as well as a potent CD8+ T cell response.